查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519736

2024-2032 年按類型、配銷通路、應用和地區分類的經皮皮膚貼片市場報告

Transdermal Skin Patches Market Report by Type, Distribution Channel, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球經皮皮膚貼片市場規模達79億美元。

經皮皮膚貼片是指一種非侵入性且易於使用的藥物傳遞方法，可在預定時間內將恆定且一致的治療劑量注入血液中。它們由背襯、藥物、薄膜、黏合劑、襯墊、化學增強劑和滲透劑、物理輔助設備以及離子電滲療法等低電流組成。它們提供一致的擴散速率，取決於皮膚的特性和貼片的設計。如今，它們在世界各地被廣泛用作化妝品、外用和經皮給藥系統。

經皮皮膚貼片市場趨勢：

經皮皮膚貼片可有效治療心臟和荷爾蒙失調、偏頭痛、帕金森氏症、阿茲海默症、中風、人類免疫缺陷病毒 (HIV)、骨質疏鬆症和不寧腿症候群。因此，患有這些疾病的人口比例的顯著增加是推動市場成長的關鍵因素之一。此外，這些貼劑有助於避免傳統的口服藥物攝取途徑，減少靜脈或腸胃外治療造成的不便，並預防胃腸道毒性、噁心和嘔吐。此外，由於給藥方便，經皮皮膚貼片越來越受到關注，以提高患者在長期治療慢性疼痛和戒菸治療期間的依從性。除此之外，以可負擔的成本獲得更好的治療方法的需求不斷增加，加上不同藥物類別的臨床試驗數量顯著增加，正在對市場產生積極影響。此外，壓敏膠合劑和滲透促進劑的引入可增加產品擴散並增強藥物保留能力，預計將為市場參與者提供有利可圖的機會，並在未來幾年擴大經皮皮膚貼片在全球的應用。

本報告回答的關鍵問題

  • 2023年全球經皮皮膚貼片市場規模有多大？
  • 2024-2032年全球經皮皮膚貼片市場的預期成長率為何？
  • 推動全球經皮皮膚貼片市場的關鍵因素是什麼？
  • COVID-19 對全球經皮皮膚貼片市場有何影響？
  • 根據類型，全球經皮皮膚貼片市場的細分如何？
  • 根據應用，全球經皮皮膚貼片市場的細分如何？
  • 全球經皮貼片市場的關鍵區域有哪些？
  • 全球經皮皮膚貼片市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球經皮皮膚貼片市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 單層藥物黏合劑
    • 市場走向
    • 市場預測
  • 多層藥物黏合劑
    • 市場走向
    • 市場預測
  • 矩陣
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路商店
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 緩解疼痛
    • 市場走向
    • 市場預測
  • 減少吸菸和戒菸援助
    • 市場走向
    • 市場預測
  • 膀胱過動症
    • 市場走向
    • 市場預測
  • 荷爾蒙療法
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
    • tesa SE (Beiersdorf AG)
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112024A5142

The global transdermal skin patches market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, distribution channel and application.

Breakup by Type:

Single-layer Drug-in-Adhesive

Multi-layer Drug-in-Adhesive

Matrix

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by Application:

Pain Relief

Smoking Reduction and Cessation Aid

Overactive Bladder

Hormonal Therapy

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global transdermal skin patches market in 2023?
  • 2. What is the expected growth rate of the global transdermal skin patches market during 2024-2032?
  • 3. What are the key factors driving the global transdermal skin patches market?
  • 4. What has been the impact of COVID-19 on the global transdermal skin patches market?
  • 5. What is the breakup of the global transdermal skin patches market based on the type?
  • 6. What is the breakup of the global transdermal skin patches market based on the application?
  • 7. What are the key regions in the global transdermal skin patches market?
  • 8. Who are the key players/companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players